G1 Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Umstead John W. V unloaded Company’s shares for reported $19752.0 on Mar 18 ’24. In the deal valued at $3.02 per share,6,547 shares were sold. As a result of this transaction, Umstead John W. V now holds 123,896 shares worth roughly $ 0.51 million.
Then, Malik Rajesh sold 28,600 shares, generating $132,143 in total proceeds. Upon selling the shares at $4.62, the Chief Medical Officer now owns 169,938 shares.
Before that, MURDOCK TERRY L sold 721 shares. G1 Therapeutics Inc shares valued at $2,121 were divested by the Chief Operating Officer at a price of $2.94 per share. As a result of the transaction, MURDOCK TERRY L now holds 103,638 shares, worth roughly $0.43 million.
JP Morgan upgraded its G1 Therapeutics Inc [GTHX] rating to a Neutral from a an Underweight in a research note published on January 30, 2023; the price target was increased to $10 from $7. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in early January has reiterated a ‘”a Buy”‘ rating for it. JP Morgan also remained covering GTHX and has decreased its forecast on November 04, 2021 with a “an Underweight” recommendation from previously “Neutral” rating.
Price Performance Review of GTHX
On Friday, G1 Therapeutics Inc [NASDAQ:GTHX] saw its stock fall -1.44% to $4.11. Over the last five days, the stock has lost -9.67%. G1 Therapeutics Inc shares have risen nearly 34.75% since the year began. Nevertheless, the stocks have risen 38.85% over the past one year. While a 52-week high of $5.00 was reached on 02/08/24, a 52-week low of $1.08 was recorded on 02/13/24. SMA at 50 days reached $3.68, while 200 days put it at $2.58. A total of 0.73 million shares were traded, compared to the trading of 0.69 million shares in the previous session.
Levels Of Support And Resistance For GTHX Stock
The 24-hour chart illustrates a support level at 3.95, which if violated will result in even more drops to 3.79. On the upside, there is a resistance level at 4.29. A further resistance level may holdings at 4.47. The Relative Strength Index (RSI) on the 14-day chart is 48.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.41%. Stochastics %K at 22.51% indicates the stock is a holding.
